• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

11
1
1
1

COUNTRY

1

CATEGORIES

  • 5
  • 5
  • 5
  • 4
  • 4
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1

PRICE

1
1
6
22

PUBLISHED

5
5
8
22

PRODUCT TYPE

21
1

Search "Respiratory Diseases: Current and Future Therapeutic Approaches and Market Opportunities" returned 22 results.

PRODUCT TITLE
Pediatric Drugs and Vaccines - Global Strategic Business Report Pediatric Drugs and Vaccines - Global Strategic Business Report - Product Thumbnail Image

Pediatric Drugs and Vaccines - Global Strategic Business Report

This report analyzes the worldwide markets for Pediatric Drugs and Vaccines in US$ Million by the following Therapeutic Class: Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective...

September 2014
FROM
Nitric Oxide - Therapeutics, Markets and Companies Nitric Oxide - Therapeutics, Markets and Companies - Product Thumbnail Image

Nitric Oxide - Therapeutics, Markets and Companies

This report describes the latest concepts of the role of nitric oxide (NO) in health and disease as a basis for therapeutics and development of new drugs. Major segments of the market for nitric oxide-based...

March 2015
FROM
Antiviral Therapeutics - Technologies, Markets and Companies Antiviral Therapeutics - Technologies, Markets and Companies - Product Thumbnail Image

Antiviral Therapeutics - Technologies, Markets and Companies

This report reviews the current state-of-art of antiviral approaches including vaccines, pharmaceuticals and innovative technologies for delivery of therapeutics. The introduction starts with a practical...

March 2015
FROM

PharmaPoint: Pediatric Respiratory Syncytial Virus (RSV) Prophylactics - US Drug Forecast and Market Analysis to 2022

PharmaPoint: Pediatric Respiratory Syncytial Virus (RSV) Prophylactics - US Drug Forecast and Market Analysis to 2022 Summary Respiratory syncytial virus (RSV) is a common cause of pediatric respiratory...

April 2013
FROM
Delivering RNAi-Based Therapeutics & Diagnostics: Challenges & Opportunities Delivering RNAi-Based Therapeutics & Diagnostics: Challenges & Opportunities - Product Thumbnail Image

Delivering RNAi-Based Therapeutics & Diagnostics: Challenges & Opportunities

This cutting edge & insightful report can be used to interpret & assess the potential of RNAi-based medicines It provides opinions & market projections to: - assess the commercial potential of RNAi-based...

July 2009
Emerging Drug Delivery Technologies & Strategies - Players, Pipelines & Partnerships Emerging Drug Delivery Technologies & Strategies - Players, Pipelines & Partnerships - Product Thumbnail Image

Emerging Drug Delivery Technologies & Strategies - Players, Pipelines & Partnerships

A major new 3-volume report from Espicom featuring: - An examination of trends and advances in the three major drug delivery sectors - Unique sales forecasts to 2020 for key products - Critical analyses...

September 2011
FROM
Gene Therapy - Technologies, Markets and Companies Gene Therapy - Technologies, Markets and Companies - Product Thumbnail Image

Gene Therapy - Technologies, Markets and Companies

Gene therapy can be broadly defined as the transfer of defined genetic material to specific target cells of a patient for the ultimate purpose of preventing or altering a particular disease state. Genes...

March 2015
FROM
Personalized Medicine - Scientific and Commercial Aspects Personalized Medicine - Scientific and Commercial Aspects - Product Thumbnail Image

Personalized Medicine - Scientific and Commercial Aspects

The aim of personalized medicine or individualized treatment is to match the right drug to the right patient and, in some cases, even to design the appropriate treatment for a patient according to his/her...

March 2015
FROM

OpportunityAnalyzer: Cystic Fibrosis Therapeutics - Opportunity Analysis and Forecasts to 2017

OpportunityAnalyzer: Cystic Fibrosis Therapeutics - Opportunity Analysis and Forecasts to 2017 Summary Cystic Fibrosis (CF) is an autosomal recessive disease characterized by the secretion of thick,...

April 2013
FROM
Molecular Diagnostics - Technologies, Markets and Companies Molecular Diagnostics - Technologies, Markets and Companies - Product Thumbnail Image

Molecular Diagnostics - Technologies, Markets and Companies

This report describes and evaluates the molecular diagnostics technologies that will play an important role in practice of medicine, public health, pharmaceutical industry, forensics and biological...

March 2015
FROM
2011 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities 2011 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities - Product Thumbnail Image

2011 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities

This report includes details on 408 emerging medical technology companies that: have presented at a 2011 LSI Emerging Medical Technologies Spotlight meeting or have been identified by LSI's in-house...

December 2011
FROM
Emerging Medical Technologies Spotlight, A Report Of Investment & Partnering Opportunities, 2011 Emerging Medical Technologies Spotlight, A Report Of Investment & Partnering Opportunities, 2011 - Product Thumbnail Image

Emerging Medical Technologies Spotlight, A Report Of Investment & Partnering Opportunities, 2011

This report includes details on 408 emerging medical technology companies that: have presented at a 2011 LSI Emerging Medical Technologies Spotlight meeting or have been identified by LSI's in-house...

December 2011
FROM

Pharmaceutical Leaders 2012 - Key Trends, Emerging Strategies and Financial Analysis of the Top Performers

Pharmaceutical Leaders 2012 - Key Trends, Emerging Strategies and Financial Analysis of the Top Performers Summary Our “Pharmaceutical Leaders 2012 - Key Trends, Emerging Strategies and Financial...

July 2012
FROM

OEM Contract Manufacturing in Medical Devices, Vol II: Electronics and Advanced Systems

Abundant opportunities are available for electronics and advanced systems companies who enter the outsourcing medical device manufacturing market; but the market is competitive and information has been...

October 2007
FROM

Contract Manufacturing in Medical Devices (Raw Materials, Electroinics and Finished Products Markets)

The trend of medical device outsourcing, or contract manufacturing is increasing. This Kalorama Information report takes an exhaustive look at the total market of OEMs outsourcing device manufacture...

November 2007
FROM

Viral Molecular Diagnostics: Market Developments, Growth Areas and Opportunities 2014

In general, viral diagnostic tests can be grouped into three areas, namely, direct detection, indirect examination following virus isolation, and serology Direct methods generally test for virus particles,...

March 2014
FROM

World Market for Molecular Diagnostics, 5th. Edition (Infectious Disease, Oncology, Blood Screening, Pre-Natal and Other Areas)

Molecular diagnostics is becoming a dominant platform in clinical medicine and represents one of the fastest growing segments of the IVD market.  As analyst Shara Rosen, R.T., MBA. details, in recent...

January 2013
FROM

OpportunityAnalyzer: Allergic Rhinitis: Allergen-Specific Immunotherapy - Opportunity Analysis and Forecast to 2018

OpportunityAnalyzer: Allergic Rhinitis: Allergen-Specific Immunotherapy - Opportunity Analysis and Forecast to 2018 Summary The global specific immunotherapy (SIT) market for allergic rhinitis (AR)...

September 2014
FROM

The World Market for Molecular Diagnostics, 4th. Edition (Infectious Disease, Oncology, Blood Screening, Pre-Natal and Other Areas): Potential and Reality, What's Hot and What's Not

This report The World Market for Molecular Diagnostics: Potential and Reality, What's Hot and What's Not estimates the market for molecular diagnostics and provides a realistic look at the role of molecular...

March 2011
FROM

Probiotics and Health Claims

This book examines the international picture regarding probiotic food applications, placing a particular emphasis on the legal context and assessment procedures of probiotic health claims in the major...

January 2011
Loading Indicator

Our Clients

Glanbia Plc. Unilever N.V. Microsoft Corporation Duke University A.T. Kearney PepsiCo Inc. Boston Consulting Group